TY - JOUR
T1 - Special patient populations
T2 - Onychomycosis in the diabetic patient
AU - Rich, Phoebe
N1 - Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 1996
Y1 - 1996
N2 - There are approximately 14 million persons with diabetes in the United States. These patients must cope with the serious complications of this disease, including neuropathy and impaired circulation (leading to the "diabetic foot" and possible amputation), renal disease, cardiovascular disease, and retinopathy (possibly leading to blindness). Although onychomycosis is no more common in diabetics than in the general population, it poses a greater risk because of the possible sequelae. Most notably, impaired sensation can make many diabetics less aware of minor abrasions and ulcerations on their feet that may be caused by trauma from poor nail grooming or by the nail changes characteristic of onychomycosis. These lesions, in turn, may develop into serious bacterial infections and contribute to the severity of the diabetic foot. Thus there is an important clinical rationale for treating diabetic patients with fungal nail infections. A secondary benefit is the improved self-esteem and enhanced quality of life.
AB - There are approximately 14 million persons with diabetes in the United States. These patients must cope with the serious complications of this disease, including neuropathy and impaired circulation (leading to the "diabetic foot" and possible amputation), renal disease, cardiovascular disease, and retinopathy (possibly leading to blindness). Although onychomycosis is no more common in diabetics than in the general population, it poses a greater risk because of the possible sequelae. Most notably, impaired sensation can make many diabetics less aware of minor abrasions and ulcerations on their feet that may be caused by trauma from poor nail grooming or by the nail changes characteristic of onychomycosis. These lesions, in turn, may develop into serious bacterial infections and contribute to the severity of the diabetic foot. Thus there is an important clinical rationale for treating diabetic patients with fungal nail infections. A secondary benefit is the improved self-esteem and enhanced quality of life.
UR - http://www.scopus.com/inward/record.url?scp=0029763067&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029763067&partnerID=8YFLogxK
U2 - 10.1016/s0190-9622(96)90063-8
DO - 10.1016/s0190-9622(96)90063-8
M3 - Article
C2 - 8784304
AN - SCOPUS:0029763067
SN - 0190-9622
VL - 35
SP - S10-S12
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 3 PART II
ER -